Skip to main content
Clinical Trials/NCT00596765
NCT00596765
Completed
Not Applicable

Phase 2 Study of Neuropsychological Therapy for Patients With Acquired Brain Injury Focusing on the Role of Psychosocial Adjustment Using a Cognitive Behavioral Approach

Philipps University Marburg Medical Center2 sites in 1 country62 target enrollmentSeptember 2007
ConditionsBrain Injury

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Brain Injury
Sponsor
Philipps University Marburg Medical Center
Enrollment
62
Locations
2
Primary Endpoint
Psychosocial Adjustment/ Everyday Functioning as a composite score of SCL-90-R and AFIB
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Acquired brain injury can result in impaired everyday functioning as well as psychosocial problems, including depressive symptoms, irritability, or negative self-concept. The purpose of this study is to determine whether a combination of neuropsychological and cognitive behavioral therapy is effective in the treatment of these sequelae.

Detailed Description

Acquired brain injury (ABI) commonly results in persistent cognitive, emotional and motivational problems. About 50% of patients involved develop psychiatric illness, most likely in the first year following ABI, which is associated with reduced psychosocial functioning and less favorable rehabilitation outcome. Treatment of these complex conditions requires a combination of neuropsychological and psychotherapeutic intervention techniques. This study aims at evaluating a combination of neuropsychological intervention methods, which include developing and using compensation strategies for cognitive impairments (attention, memory and executive functions), and psychotherapeutic intervention focusing on emotion regulation, developing positive self-concepts and adjustment of life-goals. These therapeutic interventions are modularized and patients are assigned to intervention modules according to results of objective neuropsychological testing and interviews.

Registry
clinicaltrials.gov
Start Date
September 2007
End Date
March 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Winfried Rief

Prof. Dr. Winfried Rief

Philipps University Marburg Medical Center

Eligibility Criteria

Inclusion Criteria

  • Having suffered an acquired brain injury after the age of 14, such as traumatic brain injury, neoplasm (after surgery), toxic brain damage, or brain damages through inflammatory diseases
  • Being at least 3 months post injury
  • Being German-speaking
  • Agreeing to participate, verified by completion of informed consent

Exclusion Criteria

  • Suffering from recurrent, degenerative, or progressive neurological diseases (e.g. multiple sclerosis, dementia, Chorea Huntington)
  • Current or past psychosis or bipolar disorder
  • Current or past diagnosis of substance dependency
  • History of mental retardation
  • Currently in psychotherapy
  • Severe lateralized disorder (e.g. aphasia, neglect)
  • Lacking minimum basic skills for attending therapy (e.g. not orientated to person, place, time, and events; unable to sustain attention for an hour-long session; cannot state cognitive strengths and weaknesses; cannot state areas in everyday functioning that are impaired due to the acquired brain injury)

Outcomes

Primary Outcomes

Psychosocial Adjustment/ Everyday Functioning as a composite score of SCL-90-R and AFIB

Time Frame: Pre-/ Post-Design, including 3 ponts of measurement: at the beginning of therapy/ waiting period; immediately after completion of therapy/ waiting period; catamnestic measurement 6 months later

Secondary Outcomes

  • Quality of Life (Qolibri, Seiqol, SWLS)(Pre-/ Post-Design, including 3 points of measurement: at the beginning of therapy/ waiting period; immediately after completion of therapy/ waiting period; catamnestic measurement 6 months later)
  • Psychopathology/ Affect (ADS; PANAS)(Pre-/ Post-Design, including 3 points of measurement: at the beginning of therapy/ waiting period; immediately after completion of therapy/ waiting period; catamnestic measurement 6 months later)
  • Community Integration (CIQ)(Pre-/ Post-Design, including 3 points of measurement: at the beginning of therapy/ waiting period; immediately after completion of therapy/ waiting period; catamnestic measurement 6 months later)
  • Self-concept/ Life Goals (HISDS II; GOALS; RSES-REV; Self-complexity Measure; FSKN)(Pre-/ Post-Design, including 3 points of measurement: at the beginning of therapy/ waiting period; immediately after completion of therapy/ waiting period; catamnestic measurement 6 months later)

Study Sites (2)

Loading locations...

Similar Trials